Silvia Coha

Silvia Coha is an accomplished professional in the pharmaceutical and cosmetic industries, currently serving as CEO of Effegilab Srl since March 2024. Prior to this, Silvia held the position of Technical & Scientific Manager at Just Italia S.p.a. from April 2015 to February 2024, where responsibilities included planning and implementing Italian cosmetic product launches and overseeing scientific training for field force teams. Silvia's experience at Novartis from January 2012 to March 2015 included roles as Regional Disease Area Leader for Tuberous Sclerosis Complex and Brand Leader for Tasigna, focusing on European marketing strategies. Previous experience encompasses positions at GlaxoSmithKline and Roche Pharmaceuticals, where Silvia contributed to oncology and hematology operations and brand management. Academic qualifications include a degree in Medical Biotechnology from Università degli Studi di Torino and a program in business culture and organization for life sciences at ISTUD Business School.